Table 1

Two-way (paired) comparisons between the long-term oxygen therapy (LTOT) and nasal high flow (NHF) groups

VariableLTOTNHFp Value
Oxygen saturation (%)*95.8 (94.6 to 96.9)95.7 (93.1 to 97.1)0.06
Transcutaneous O2 (mm Hg)101.2 (22.5)97.1 (24.2)0.01
Transcutaneous CO2 (mm Hg)46.7 (9.4)43.3 (9.5)<0.001
Respiratory rate (breaths/min)19.2 (6.3)15.4 (4.8)0.001
Inspiratory:expiratory ratio0.86 (0.20)0.75 (0.25)0.02
Tidal volume (L)*0.40 (0.34, 0.46)0.50 (0.41, 0.54)0.003
Minute volume (L/min)*6.20 (4.84, 8.18)6.18 (4.75, 7.69)0.88
Heart rate (beats/min)70.1 (59.1, 79.3)69.8 (61.3, 79.8)0.21
End-expiratory lung impedance (%Δ)*113 (98, 128)174 (161, 187)<0.001
  • A p value <0.05 was considered significant. Normally distributed data are presented as mean (SD) while non-normal data are presented as median (IQR). End-expiratory lung impedance data are presented as percentage change from baseline (%Δ). All variables returned to baseline values during the washout periods and subsequently during the recovery period.

  • *A paired t test was used for the normally distributed data while a Wilcoxon signed rank test was used for the non-normal data.